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Abstract: Colonization and infection by multidrug-resistant gram-
negative bacilli (MDR GNB) in neonatal intensive care units (NICUs)
are increasingly reported.
We conducted a 5-year prospective cohort surveillance study in a
tertiary NICU of the hospital ‘‘Paolo Giaccone,’’ Palermo, Italy. Our
objectives were to describe incidence and trends of MDR GNB colo-
nization and the characteristics of the most prevalent organisms and to
identify the risk factors for colonization. Demographic, clinical, and
microbiological data were prospectively collected. Active surveillance
cultures (ASCs) were obtained weekly. Clusters of colonization by
extended spectrum b-lactamase (ESBL) producing Escherichia coli and
Klebsiella pneumoniae were analyzed by conventional and molecular
epidemiological tools.
During the study period, 1152 infants were enrolled in the study.
Prevalences of colonization by MDR GNB, ESBL-producing GNB and
multiple species/genera averaged, respectively, 28.8%, 11.7%, and
3.7%. Prevalence and incidence density of colonization by MDR
GNB and ESBL-producing GNB showed an upward trend through
the surveillance period. Rates of ESBL-producing E coli and K pneu-
moniae colonization showed wide fluctuations peaking over the last 2
years. The only independent variables associated with colonization by
MDR GNB and ESBL-producing organisms and multiple colonization
were, respectively, the days of NICU stay (odds ratio [OR] 1.041), the
days of exposure to ampicillin–sulbactam (OR 1.040), and the days of
formula feeding (OR 1.031). Most clusters of E coli and K pneumoniae
colonization were associated with different lineages. Ten out of 12
clusters had an outborn infant as their index case.
Our study confirms that MDR GNB are an increasing challenge to
NICUs. The universal once-a-week approach allowed us to understand
the epidemiology of MDR GNB, to timely detect new clones and
institute contact precautions, and to assess risk factors. Collection of
these data can be an important tool to optimize antimicrobials use and
control the emergence and dissemination of resistances in NICU.
(Medicine 95(10):e3016)
Abbreviations: ASC = active surveillance culture, ATCC =
American Type Culture Collection, CI = confidence interval,
ESBL = extended spectrum b-lactamase, EUCAST = European
Committee on Antimicrobial Susceptibility Testing, GNB = gram-
negative bacilli, IQR = interquartile range, MDR = multidrug
resistant, MLST = multilocus sequence typing, MRSA =
methicillin resistant Staphylococcus aureus, nCPAP = nasal
continuous positive airway pressure, NICU = neonatal intensive
care unit, OR = odds ratio, PCR = polymerase chain reaction,
PFGE = pulsed field gel electrophoresis, ST = sequence type.
INTRODUCTION
M ultidrug-resistant (MDR) gram-negative bacilli (GNB)are unanimously acknowledged as posing one of the most
worrisome challenges in the field of both healthcare associated
and community-acquired infections.1 Their clinical impact is
even more concerning in the neonatal and pediatric care settings
where options for treatment are intrinsically limited.2 Neonatal
intensive care units (NICUs), in particular, can be especially
prone to the spread of MDR GNB because of the largely
unavoidable exposure to multiple risk factors by critically
susceptible subjects.2,3 Outbreaks can bring severe consequences
in terms of bothmorbidity andmortality and strict riskmitigation
strategies, such as restriction of admissions, ward closure, and,
ultimately, disruption of healthcare services.4,5 However, ende-
mic circulation ofMDRGNB in NICU can be difficult to control
as well.6,7 Trading of MDR GNB and their resistance determi-
nants between healthcare facilities and community is adding
further complexity to this puzzling landscape.8,9
Many risk factors and underlying conditions have been
identified in association with MDR GNB acquisition in NICU,
such as low gestational age, length of stay, use of antibiotics,
and exposure to invasive devices.3,10–13 Intestinal MDR GNB
colonization also plays a role as a risk factor for infection:
according with literature data, indeed, up to 50% of infants
colonized by MDR GNB, in particular by extended spectrum
b-lactamase (ESBL)-producing bacteria, can develop blood-
stream infection.14,15
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In the light of the rapidly evolving epidemiological land-
scape in reference to logistic and organizational aspects in
NICU, characteristics of admitted infants, and pattern of the
prominent MDR organisms, the objectives of this study were to
describe through a 5-year period of surveillance incidence and
trends of MDR GNB colonization and the main characteristics
of the most frequently detected colonizing organisms and to
identify the risk factors associated with colonization.
METHODS
Study Design, Study Setting, and Patients
We conducted a 5-year prospective cohort surveillance
study integrated with a program of active surveillance cultures
(ASCs). The setting was the tertiary NICU of the teaching
hospital ‘‘Paolo Giaccone,’’ Palermo, Italy. This NICU annually
admits "250 infants of all gestational ages. Because it is
associated with the regional reference centre for genetic dis-
eases, the NICU has a high prevalence of neonates with
malformation ("20%), as well as of outborn admissions
("35%). Moreover, a further 20% proportion of patients is
affected by complex conditions requiring subspecialty medical
or surgical care. The NICU includes 1 intensive care room
consisting of 8 cot spaces and 1 intermediate care room
including 8 further cot spaces. The average nurse to patient
ratio is 1:3 and 1:4 in the 2 sections, respectively. The NICU
ward is open to parents for 2 hours in the morning and 4 hours in
the afternoon so that they can be progressively trained in the
general care of their child under the guidance and supervision of
the staff. Early breastfeeding is encouraged.
Inclusion criteria were admission to NICU between June
16, 2009, and June 15, 2014, a hospital stay of at least 48 hours,
and the collection of at least 1 rectal swab. Demographic,
clinical, and microbiological data were prospectively collected.
At admission demographic characteristics, gestational age, birth
weight, inborn or outborn condition, delivery type, APGAR
score, and comorbid conditions were recorded. During the
NICU stay, qualitative and quantitative data were collected
about the following variables: presence of central vascular
access devices, endotracheal intubation and mechanical venti-
lation, nasal continuous positive airway pressure (nCPAP),
peripheral catheters, type of feeding (i.e., parenteral nutrition,
enteral nutrition with oral suction or gavage, breast milk,
formula), surgery, antibacterial drug therapy, length of stay,
and survival status at discharge.
Infants were categorized as colonized by MDR GNB when
at least 1 rectal swab tested positive.
Clustering of colonization cases by MDR Escherichia coli
(E coli) and Klebsiella pneumoniae (K pneumoniae) was first
hypothesized on the basis of the antibacterial drug resistance
profile (both qualitative, i.e., susceptible, intermediately resist-
ant or resistant, and quantitative, i.e., mm of the inhibition
halos) and the staying interval in the NICU. Cases were defined
as putatively clustered when they were colonized by isolates of
E coli or K pneumoniae with indistinguishable resistance pro-
files and hospitalized during periods overlapping for at least
48 hours. Clustering was confirmed by pulsed field gel electro-
phoresis (PFGE) including only indistinguishable and closely
related isolates.16
Criteria from the Centers for Disease Control and Preven-
tion were applied to define neonatal infection and sepsis.17 Both
culture proven and culture negative infection cases were
counted. Ampicillin–sulbactam and gentamicin were the
recommended first-line empiric therapy in most cases of
suspected infection, both early and late onset, according to
our data on the prevailing bacterial flora in our setting. Usage of
third-generation cephalosporins was not recommended.
The study protocol was approved by the Ethics Committee
of the Azienda Ospedaliero-Universitaria Policlinico ‘‘P. Giac-
cone,’’ Palermo, Italy, and informed consent was sought in
accordance with the principles of the Declaration of Helsinki.
Written informed consent was obtained from the parents or
guardians of the neonates.
Infection Control Interventions
Since June 2009, a surveillance protocol is routinely
running, which includes nasal and rectal swabs obtained on a
weekly basis from all infants staying in the NICU to monitor the
prevalence of carriage with methicillin-resistant Staphylococ-
cus aureus (MRSA), MDR GNB and glycopeptide-resistant
enterococci. Universal screening at admission is not performed.
A policy of appropriate managing of invasive devices is well
established in the NICU, including removal of umbilical venous
catheter at 72 hours and replacement of any further central
venous line within a maximum of 21 days and in any case of
suspected/documented bloodstream infection.
Measures taken to control MDR organisms in the NICU
include contact precautions, use of dedicated equipment and
cyclic training sessions on hand hygiene, and cleaning and
disinfection procedures. Moreover, special attention is paid
to prevent overcrowding and relative understaffing, to minimize
length of hospital stay, and to promote a safe use of invasive
devices. Cohorting is adopted, when necessary, but without
dedicated nursing staff due to its chronic shortage.
Intensified NICU cleaning is performed when clusters of
colonization cases by MDR GNB are suspected. Routine
environmental cultures are not performed.
Microbiological Study
Rectal swabs were collected weekly each Monday. They
were pre-enriched in Brain Hearth Infusion broth overnight
before being plated on MacConkey agar. Four antibiotic disks,
containing gentamicin (10mg), amoxicillin-clavulanic acid (20–
10mg),meropenem (10mg), and ceftazidime (30mg)were placed
on each plate before incubation. These antimicrobial drugs were
selected in order to include the 2 more frequently used antibac-
terial drugs inNICU, gentamicin andamoxicillin-clavulanic acid,
and 2 further antibiotics, such as ceftazidime and meropenem,
that could allow for timely detecting most gram-negative organ-
isms resistant to cephalosporins and/or carbapenems. Colonies
growing into antibiotic inhibition halos were subcultured, bio-
chemically identified by home-made biochemical tests and/or
API20E strips (Biome´rieux, Marne-La Coquette, France), and
submitted to antibiotic susceptibility testing. Isolates attributed
with Enterobacter spp. were not further speciated.
Antibiotic susceptibility testing and ESBL detection were
first performed by disk diffusion and double disk synergy test and
then confirmed by Etest (Biome´rieux, Marcy l’E´toile, France)
methods according with the European Committee on Antimicro-
bial Susceptibility Testing (EUCAST) guidelines.18 An isolate
was defined as resistant to third-generation cephalosporins, when
the inhibition zone diameter of ceftriaxone (30mg) and cefotax-
ime (5mg) was<20mm and 17mm, respectively. An isolate was
defined asMDRwhen it was proved to be resistant to at least 3 of
the classes of antibacterial drugs under testing (amoxicillin
clavulanic, third/fourth-generation cephalosporins, monobac-
tams, aminoglycosides, carbapenems).
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E coli ATCC 25922 was used as quality control strain.
E coli and K pneumoniae isolates belonging to each of the
epidemic clusters were further characterized by molecular
typing. Multiplex polymerase chian reactions (PCRs) were used
to amplify genes encoding ESBLs and amplicons were
sequenced.19 E coli phylogenetic group was determined by a
triplex polymerase chain reaction (PCR) assay as described
previously.20 Pulsed field gel electrophoresis (PFGE) was per-
formed and electrophoretic profiles interpreted according to
standard procedures.16 E coli representative isolates were
further characterized by MultiLocus Sequence Typing (MLST)
according to the University College Cork (Cork, Ireland)
scheme for E coli (http://mlst.ucc.ie/mlst/dbs/Ecoli). MLST
of selected MDR K pneumoniae isolates was also performed
according to the guidelines available on the Pasteur Institute
MLSTwebsite (http://www.pasteur.fr/recherche/genopole/PF8/
mlst/Kpneumoniae.html).
Statistical Analysis
The association between potential risk factors and MDR
GNB colonization was analyzed for variables present at admis-
sion and during the NICU stay. Time-dependent variables, that
is, length of stay, nutrition, invasive procedures, and antimi-
crobial use, were also measured as days between admission and
discharge, death or referral to other healthcare facilities,
because patients were assumed to be at risk of further coloniza-
tion by a different species or strain of MDR GNB after their
first isolation.
Categorical variables were compared by using the x2 test
or Fisher’s exact test. Continuous variables were compared by
theMann–WhitneyU test or the ANOVA 1-way test, depending
on the distributions. The x2 for trend was calculated with the
Mantel–Haenzsel test. All tests were 2-sided, with P < 0.05
considered to indicate significance.
Multivariate logistic regression using the forward step
method was used to predict colonization by MDR GNB,
ESBL-producing GNB, and multiple MDR GNB. Multivariate
logistic regression analysis included all statistically significant
variables with P< 0.05 in univariate analysis, and gender and
gestational age, whether or not they were statistically signifi-
cant. Goodness-of-fit statistics were calculated and variables
were checked for collinearity using conditional indices. The
analysis was performed using the softwares EpiInfo, ver. 7,
(Centers for Disease Control and Prevention, Atlanta, GA) and
SPSS, version 20.0 (IBM SPSS Statistics, IBM Corporation,
Armonk, NY).
RESULTS
Characteristics at Admission
During the study period, 1152 out of 1374 infants admitted
to the NICU fulfilled the inclusion criteria. Among them, 873
(75.7%) were admitted within 24 hours after birth. In >60% of
the infants the gestational age was >36 weeks and the birth
weight >2500 g. Proportion of inborn was "60%.
The annual outborn proportion of admissions raised from
34.9% to 45.7%, even though the increase was not statistically
significant (x2 for trend P¼ 0.16). Proportion of malformation
was 19.1%, ranging from a minimum of 17.2% in the 2nd year
to a maximum of 20.0% in the 5th year (x2 for trend P¼ 0.79).
Meanwhile, birth weight proved to range from a mean of
2668.5 g (median 2750.0 g, interquartile range [IQR]
2170.0–3230.0 g) in the 1st year to a mean of 2800.9 g (median
2750.0 g, IQR 2280.0$3290.0 g) in the 5th year, with a peak in
the 4th year (mean 2941.9 g [median 2940.0 g, IQR 2250.0
$3320.0 g] (ANOVA, F 3.16; Bonferroni test: 3rd vs 4th year,
P¼ 0.007).
The average length of stay was 18.9 days (median 11 days,
IQR 7–22 days). Over the study period the median length
increased from 9 days, IQR 7–22 days, in the 1st year to 13
days, IQR 8–26 days, in the 3rd year, and again decreased to 11
days, IQR 9–18 days in the 5th year (ANOVA, F 1.71;
Bonferroni test: 3rd vs 5th year, P¼ 0.29).
The characteristics of the infants at admission are sum-
marized in Table 1.
MDR GNB Colonization and Trend in the 5-Year
Period
During the 5-year period of surveillance 332 (28.8%)
infants tested positive for intestinal colonization by at least 1
species/genus of MDR GNB. The prevalence of colonization
showed a steady upward trend from 20.6% in the 1st year to
35.9% in the last year (2nd year 25.0%, 3rd year 32.7%, 4th year
31.3%). Prevalence of colonization by ESBL-producing GNB
averaged 11.7% (135 infants out of 1152) ranging between a
minimum of 6.6% in the 1st year and a maximum of 20.1% in
the 5th year, and a climbing upward trend (2nd year 7.6%, 3rd
year 10.8%, 4th year 14.6%).
The mean prevalence of multiple colonization by different
MDR GNB genera/species was 3.6% (42 infants out of 1152)
with a more stable trend and annual rates ranging between a
minimum of 2.1% in the 4th year and a maximum of 5.1% in the
1st year of surveillance.
TABLE 1. General Characteristics of Patients at Admission to
the NICU (June 2009 to June 2014, Palermo, Italy)
Variables No. (%)
Total, no. (% by row) 1152 (100)
Gender
Males 670 (58.2)
Age at admission, h
<24 h 873 (75.7)
24 to 48 h 138 (12.1)
>48 h 139 (12.2)
Gestational age, weeks
<30 weeks 47 (4.1)
30–36 weeks 380 (33.0)
>36 weeks 725 (62.9)
Birth weight, g
%1000 g 31 (2.7)
1001–1500 g 60 (5.2)
1501–2000 g 135 (11.7)
2001–2500 g 210 (18.2)
>2500 g 716 (62.2)
Inborn 692 (60.1)
Twin birth 147 (12.8)
Cesarean delivery 768 (66.7)
APGAR score at 5min <8 112 (9.7)
Malformation 220 (19.1)
Note: information about age at admission was only available for 1150
infants.
NICU¼ neonatal intensive care unit.
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Figure 1 depicts the incidence density of colonization by
MDR GNB, ESBL-producing GNB, and multiple MDR GNB
through the surveillance period. A significant upward trend was
evident for MDR GNB and ESBL-producing GNB with a
coefficient of determination of 0.95 and 0.87, respectively.
Conversely, incidence of multicolonization did not show sig-
nificant changes, ranging between a minimum of 1.1 per 1000
patient-days during the 4th year and a maximum of 2.9 per 1000
patient-days during the 1st year.
The proportion of neonates who acquired the most fre-
quently detected genera and species of MDR GNB through the
5-year period was as follows: a mean proportion of 12.9%
(range 9.6–14.8%) of neonates acquired Enterobacter spp.;
8.1% (range 1.3–17.7%) and 5.4% (range 0–13.4%), respect-
ively, acquired K pneumoniae and E coli; Citrobacter spp. was
detected in 3.5% (range 2.4–5.8%) of neonates and Pseudo-
monas aeruginosa in 1.0% (range 0–2.3%). These MDR organ-
isms accounted for "95% of the MDR GNB identified
from ASCs.
The first ESBL-producing organism to be detected was K
pneumoniae in 48 infants (35.8%), E coli in 31 (23.1), K
pneumoniae and E coli simultaneously in 29 (21.6%), and
Enterobacter spp. in 20 (14.9%). The median length of stay
between admission and the first rectal swab positive was 10
days (IQR 5–18 days). In 90 and 59 infants, respectively,
ESBL-producing K pneumoniae and E coli were detected in
2 to 5 serial rectal swabs.
A range of 1 to 11 MDR GNB positive rectal swabs were
obtained from the 42 multi-colonized neonates. Two to 4
different genera/species were identified simultaneously or in
the subsequent rectal swabs. Enterobacter spp. was identified as
one of the colonizing genera in 33 cases. The most frequent
association was Enterobacter spp. plus K pneumoniae (8 neo-
nates) followed by Enterobacter spp. plus Citrobacter spp. (7
neonates). ESBL-producing E coli and/or K pneumoniae were
identified in 22 cases of multiple colonization.
When looking at the trend of the incidence density during
the 5 years (Figure 2), rates of both E coli and K pneumoniae
colonization showed wide fluctuations peaking over the last 2
years. Conversely, incidence densities of colonization by Enter-
obacter spp., Citrobacter spp., and P aeruginosa remained
stable or slightly declining during the study period.
Risk Factors for MDR GNB Acquisition
Baseline and clinical characteristics of the neonates with
MDR GNB and non-MDR GNB are illustrated in Table 2. Most
variables present at admission and linked to a condition pre-
disposing to a longer NICU stay, such as twin birth and low birth
weight/gestational age, were significantly associated by uni-
variate analysis with being colonized by MDR GNB. Similarly,
use of invasive devices, use of antibiotics, and length of stay
proved to be significantly associated with MDR GNB coloniza-
tion. After applying a logistic regression model, the only 2
independent variables proved to be: the APGAR score at
5minutes &8 (odds ratio [OR] 0.757, 95% CI 0.631–0.907),
which associated negatively, and the days of NICU stay (OR
1.041, 95% CI 1.003–1.080), which conversely were a signifi-
cant determinant of colonization.
Risk factors for acquisition of ESBL organisms were also
analyzed (Table 3). There were statistically significant differ-
ences between the 2 groups of colonized and noncolonized
neonates regarding the number of days of exposure to central
venous access devices, parenteral nutrition, and antibiotic
therapy. Parenteral nutrition was also significantly associated
with ESBL-producing GNB acquisition as a qualitative vari-
able. After applying the logistic regression model, only the days
of exposure to ampicillin–sulbactam were an independent risk
factor (OR 1.040, 95% CI 1.009–1.071).
Finally, Table 4 summarizes the results of the analysis of
the variables associated with being colonized, simultaneously or
subsequently, by multiple genera/species of MDR GNB. Low
birth weight/gestational age, exposure to some invasive pro-
cedures and antibiotic therapy and days of breast- and formula
feeding proved to be significantly associated with multiple
colonization. The only independent risk factor by the logistic
regression was the number of days of formula feeding (OR
1.031, 95% CI 1.016–1.046). Thirty-three out of 42 (78.6%)
multicolonized infants yielded Enterobacter spp. versus 146 out
of 332 (44.0%) monocolonized (P< 0.001). No significant
differences were found for other MDR GNB species.
Infants with MDR GNB colonization had a significantly
higher rate of sepsis than those testing negative (15.5% vs
10.9%, P¼ 0.02). Similarly, a higher rate of sepsis proved to be
associated with colonization by multiple MDR GNB species or
genera (21.4% vs 11.8%, P¼ .04). Conversely, no significant
FIGURE 1. Incidence density per 1000 patient-days of coloniza-
tion by MDR GNB, ESBL-producing GNB, and multiple MDR GNB
through the surveillance period, June 2009 to June 2014, Palermo,
Italy. ESBL¼ extended spectrum b-lactamase, GNB¼gram-nega-
tive bacilli, MDR¼multidrug resistant.
FIGURE 2. Incidence density per 1000 patient-days of coloniza-
tions by E coli, K pneumoniae, Enterobacter spp., Citrobacter
spp., and P aeruginosa through the surveillance period, June
2009 to June 2014, Palermo, Italy.
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difference was found between infants colonized by ESBL
producing organisms and those who did not (15.1% vs
12.8%, P¼ 0.15).
Clustering of ESBL-Producing E Coli and K
Pneumoniae
Because of their peculiar epidemiological behavior and the
implications of the spread of ESBL-producing E coli and K
pneumoniae isolates in NICU, all isolates were analyzed and
screened for putative clustering. Except for 1 patient, who was
sequentially colonized by 2 genetically different CTX-M15 and
KPC-3-producing K pneumoniae isolates, all infants whose
serially collected rectal swabs tested repeatedly positive were
colonized by genetically indistinguishable isolates.
Table 5 describes the characteristics of the clusters of
colonization detected during the 5-year period of surveillance,
along with some molecular key features. Some aspects deserve
consideration: the great heterogeneity of the causal organisms
with the involvement of phylogroups non-B2 and B2 lineages
other than ST131 of E coli and the detection of 7 different STs of
K pneumoniae responsible for as many clusters; the predomi-
nance of CTX-M-15 as the ESBL genetic determinant in both
organisms; the influx of carbapenem-resistant K pneumoniae
strains with different genetic determinants (KPC-3 and OXA-
48) in NICU.
Finally, it is of interest that in all colonization clusters by K
pneumoniae and in 3 out of 5 clusters by E coli the index case
was an outborn infant. Except for 1 patient who had been
transferred after 48 hours of stay in the referring NICU, all
the remaining infants had been moved to our NICU within
24 hours since their birth time.
DISCUSSION
In our setting the prevalence of intestinal colonization by
MDR GNB was "30% and showed an upward trend in the 5-
year period under study. This trend was evident when looking at
the incidence density and appeared to be largely driven by the
spread of ESBL-producing gram negatives. In literature NICU
colonization rates as high as 56% of infants colonized by ESBL-
producing Enterobacteriaceae in Ecuador23or 61% by MDR
TABLE 2. Comparison Between Characteristics at Admission and During NICU Stay of MDR GNB Colonized and Noncolonized
Infants, June 2009 to June 2014, Palermo, Italy (n¼1152)
Variable Colonized (n¼ 332) Noncolonized (n¼ 820) P P
At admission
Male gender, n (%) 191 (57.5) 479 (58.4) 0.39
Twin birth, n (%) 60 (18.1) 87 (10.6) <0.001
Malformation, n (%) 69 (20.8) 151 (18.4) 0.18
Inborn, n (%) 187 (56.2) 505 (61.6) 0.05
Birth through caesarean section, n (%) 247 (74.3) 521 (63.5) <0.001
Admission to NICU > 24 h after birth, n (%) 87 (26.3) 190 (23.2) 0.13
Apgar score at 5min &8, n (%) 276 (83.0) 765 (93.3) <0.001 <0.001
Gestational age, mean (SD), wk 37.2 (3.1) 35.8 (3.5) <0.001
Birth weight, mean (SD), g 2830 (1435) 2497 (849) <0.001
During stay
Central venous access device, n (%) 141 (42.6) 222 (27.1) <0.001
Central venous access device, mean (SD), d 8.7 (13.7) 4.0 (10.6) <0.001
Endotracheal tube, n (%) 90 (27.2) 124 (15.1) <0.001
Endotracheal tube, mean (SD), d 2.2 (7.0) 1.3 (4.7) <0.001
Nasogastric tube, n (%) 160 (48.2) 245 (29.9) <0.001
Nasogastric tube, mean (SD), d 14.9 (23.7) 5.0 (12.8) <0.001
nCPAP, n (%) 91 (27.5) 128 (15.6) <0.001
nCPAP, mean (SD), d 2.2 (5.7) 0.9 (3.2) <0.001
Parenteral nutrition, n (%) 229 (69.2) 465 (56.7) <0.001
Parenteral nutrition, mean (SD), d 10.0 (13.5) 5.6 (9.4) <0.001
Surgical procedure, n (%) 37 (11.1) 72 (8.8) 0.12
Formula feeding, n (%) 320 (96.4) 774 (94.4) 0.08
Formula feeding, mean (SD), d 22.4 (21.9) 12.7 (21.2) <0.001
Breast milk feeding, n (%) 198 (59.7) 436 (53.2) 0.02
Breast milk feeding, mean (SD), d 13.5 (17.5) 6.4 (9.1) <0.001
Length of stay, mean (SD), d 27.9 (26.6) 14.0 (18.2) <0.001 <0.001
Ampicillin-sulbactam plus gentamicin, n (%) 205 (61.9) 429 (52.3) <0.001
Ampicillin-sulbactam plus gentamicin, mean (SD), d 7.4 (8.0) 4.8 (5.8) <0.001
Systemic antibacterial therapy, n (%) 212 (64.0) 443 (54.0) <0.001
Systemic antibacterial therapy, mean (SD), d 9.4 (12.2) 5.8 (9.2) <0.001
Note: P value in the first column is from univariate analysis with statistically significant values in bold, P value in the second column is from the
forward step logistic regression.
nCPAP¼ nasal continuous positive airway pressure, NICU¼ neonatal intensive care unit, SD¼ standard deviation.
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GNB in the Philippines24 are reported. However, it is complex
to compare data from different NICUs and geographic areas,
because of gross heterogeneities in the local epidemiology in
each specific area, the structural, logistic, and organizational
models of the NICUs and their surveillance policies. A further
issue of concern is the different set of antibacterial drugs
entering in the definition of an MDR organism as resistant to
at least 3 classes of them. In our experience, indeed, only
antibacterial drugs of potential use in the treatment of neonatal
infections were considered. Conversely, some authors, such as
Millar et al,8 included within the classes of antibiotics concur-
ring to the identification of an MDR isolate drugs not suitable
for neonatal treatment such as tetracycline, colistin, chloram-
phenicol, and ciprofloxacin. Additionally, samples from infec-
tion and colonization cases are frequently merged, occurrence
of outbreaks can artifactually inflate the prevalence of a strain/
clone, and only some families, such as Enterobacteriaceae, can
be considered.8,23
The primary risk factor identified for MDR–GNB colo-
nization in our study cohort was the number of days spent in
NICU. Other previously reported predictors of MDR–GNB
colonization, such as low gestational age and /or birth weight,
mechanical ventilation, feeding, parenteral nutrition, use of
invasive devices, and antibiotic exposure were not identified
as independent risk factors.5,8,10,11,13,23 The absence of other
significant associations strongly suggests the importance of
cross-transmission within the NICU.
In our setting, despite the exclusion of cephalosporins from
the NICU’s antibiotic policy, the average yearly prevalence of
ESBL producers colonization was 11.7%, but it cannot be
overlooked the upward trend of prevalence and incidence
density with roughly doubling figures in the fifth year compared
with the first one. It is evident also that CTX-M-15-producing E
coli and K pneumoniae are the main drivers of this trend. Again,
comparing prevalences of ESBL-colonized infants in different
NICUs and settings is difficult and maybe misleading, because
of the known attitude of ESBL-producing organisms to spread
by cross-transmission and to trade their ESBL genetic deter-
minants.23,25 Conversely, clinical significance of colonization
with ESBL-producing strains is well defined. Indeed, in studies
from countries with different income distribution and healthcare
systems, such as Brazil, Italy, Spain, and Switzerland, between
TABLE 3. Comparison between characteristics at admission and during NICU stay of ESBL producing bacilli colonized and non
colonized infants, June 2009–June 2014, Palermo, Italy (n¼332)
Variable ESBL negative (n¼ 198) ESBL positive (n¼ 134) P P
At admission
Male gender, n (%) 113 (57.1) 78 (58,2) 0.42
Twin birth, n (%) 36 (18.4) 24 (17.6) 0.43
Malformation, n (%) 44 (22.4) 24 (18.3) 0.18
Inborn, n (%) 110 (55.6) 77 (57.1) 0.39
Birth through caesarean section, n (%) 146 (73.7) 101 (75.2) 0.38
Admission to NICU > 24 h after birth, n (%) 33 (24.8) 54 (27.3) 0.31
Apgar score at 5min &8, n (%) 98 (79.0) 165 (85.5) 0.07
Gestational age, mean (SD), wk 35.8 (3.4) 35.9 (3.6) 0.34
Birth weight, mean (SD), g 2451 (812) 2527 (873) 0.43
During stay
Central venous access device, n (%) 59 (44.4) 82 (41.4) 0.30
Central venous access device, mean (SD), d 11.0 (15.7) 7.4 (12.2) 0.02
Endotracheal tube, n (%) 35 (26.3) 55 (27.8) 0.39
Endotracheal tube, mean (SD), d 2.4 (7.9) 2.1 (6.3) 0.97
Nasogastric tube, n (%) 66 (49.6) 94 (47.5) 0.35
Nasogastric tube, mean (SD), d 16.0 (25.2) 14.2 (22.9) 0.53
nCPAP, n (%) 35 (26.3) 56 (28.3) 0.35
nCPAP, mean (SD), d 2.6 (7.2) 1.9 (4.4) 0.95
Parenteral nutrition, n (%) 99 (74.4) 130 (65.7) 0.04
Parenteral nutrition, mean (SD), d 11.8 (16.0) 8.9 (11.5) 0.04
Surgical procedure, n (%) 15 (11.5) 21 (10.8) 0.41
Formula feeding, n (%) 129 (96.3) 190 (96.4) 0.46
Formula feeding, mean (SD), d 23.0 (22.6) 22.1 (21.4) 0.73
Breast milk feeding, n (%) 83 (62.4) 114 (57.9) 0.21
Breast milk feeding, mean (SD), d 15.8 (20.0) 11.9 (15.5) 0.09
Length of stay, mean (SD), d 29.4 (30.3) 26.8 (23.8) 0.68
Ampicillin–sulbactam plus gentamicin, n (%) 89 (66.9) 116 (58.6) 0.05
Ampicillin–sulbactam plus gentamicin, mean (SD), d 8.7 (8.4) 6.5 (7.6) 0.02 0.001
Systemic antibacterial therapy, n (%) 91 (68.4) 121 (61.1) 0.08
Systemic antibacterial therapy, mean (SD), d 11.1 (13.6) 8.4 (11.1) 0.03
Note: P value in the first column is from univariate analysis with statistically significant values in bold, P value in the second column is from the
forward step logistic regression.
nCPAP¼ nasal continuous positive airway pressure, NICU¼ neonatal intensive care unit, SD¼ standard deviation.
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12% and 50% of neonates colonized with ESBL-producing
bacteria developed bloodstream infection.11,12,26,27 When com-
paring within MDR GNB colonized infants those colonized by
ESBL-producing and nonproducing organisms, only days of
administration of ampicillin–sulbactam proved to be an inde-
pendent risk factor in the multivariate analysis. Empirical
treatment of early onset sepsis by ampicillin–gentamicin is
still thought to be appropriate on the assumption of antibacterial
drug susceptibility of the community-acquired causative organ-
isms, in particular E coli. There is a paucity of neonatal
community-acquired ESBL epidemiologic data worldwide,
but an increased prevalence of community ESBL-producing
gram negatives as etiologic agents of early neonatal sepsis has
been reported.28 In addition, most ESBL producers demonstrate
resistance to aminoglycosides as well.23,25,29 The ongoing
emergence of ESBL-producing organisms in the community
calls for vigilance in monitoring local patterns of
antibiotic susceptibility.
It is noteworthy the heterogeneity of the bacterial lineages
involved in the clusters with the identification of phylogroups
other than B2 and a B2 non-ST131 clone of E coli and 7
different STs detected among isolates of K pneumoniae
involved in as many clusters. Except for the carbapenemase-
producing ST258, a well-known pandemic clone, the remaining
lineages are not reputed as ‘‘high risk’’ clones and are also
genetically unrelated. Two infants were also detected being
colonized by an OXA-48 carbapenemase-producing K pneu-
moniae strain, with the index case being born to Tunisian
parents. Within the last years, several outbreak and sporadic
cases of OXA-48-producing Enterobacteriaceae infections
have been reported across Europe, most of which related to
patients with previous exposure to healthcare facilities in
Turkey, Middle East, and northern Africa.30–32 Our obser-
vations confirm the permeability of NICUs to the import of
MDR GNB, in particular ESBL-producing organisms, and
suggest that it is possible that as their prevalence is increasing
in the community, the likelihood of their introduction into an
NICU is increasing as well.
It is also interesting to observe the wide predominance of
outborn infants as index cases of the colonization clusters. Most
of them had been transferred in the 24 hour-interval after their
birth, but it is also well known that in low endemic setting the
TABLE 4. Comparison Between Characteristics at Admission and During NICU Stay of Colonized and Noncolonized Infants by
Multiple MDR Organisms, June 2009 to June 2014, Palermo, Italy (n¼332)
Variable Monocolonized (n¼ 290) Multicolonized (n¼ 42) P P
At admission
Male gender, n (%) 172 (59.3) 19 (45.2) 0.05
Twin birth, n (%) 53 (18.1) 7 (17.9) 0.50
Malformation, n (%) 61 (21.0) 8 (19.5) 0.43
Inborn, n (%) 164 (56.4) 23 (54.8) 0.42
Birth through caesarean section, n (%) 210 (72.5) 37 (87.2) 0.02
Admission to NICU > 24 h after birth, n (%) 79 (27.3) 8 (19.0) 0.13
Apgar score at 5min &8, n (%) 248 (85.5) 33 (79.0) 0.07
Gestational age, mean (SD), wk 33.5 (4.2) 36.2 (3.3) <0.001
Birth weight, mean (SD), g 1935 (869) 2579 (815) <0.001
During stay
Central venous access device, n (%) 112 (38.8) 29 (69.0) <0.001
Central venous access device, mean (SD), d 13.8 (13.8) 7.9 (13.5) 0.01
Endotracheal tube, n (%) 71 (24.6) 19 (45.2) 0.004
Endotracheal tube, mean (SD), d 2.9 (4.5) 2.1 (7.3) 0.01
Nasogastric tube, n (%) 128 (44.3) 32 (76.2) <0.001
Nasogastric tube, mean (SD), d 30.1 (28.1) 12.5 (22.1) <0.001
nCPAP, n (%) 35 (26.3) 56 (28.3) 0.35
nCPAP, mean (SD), d 2.6 (7.2) 1.9 (4.4) 0.95
Parenteral nutrition, n (%) 198 (68.2) 32 (76.2) 0.15
Parenteral nutrition, mean (SD), d 13.3 (14.7) 9.5 (13.3) 0.09
Surgical procedure, n (%) 33 (11.5) 3 (7.9) 0.27
Formula feeding, n (%) 280 (96.5) 40 (95.2) 0.32
Formula feeding, mean (SD), d 37.4 (28.9) 20.2 (19.8) <0.001 0.001
Breast milk feeding, n (%) 169 (58.3) 30 (69.0) 0.09
Breast milk feeding, mean (SD), d 24.2 (23.1) 11.9 (16.0) 0.001
Length of stay, mean (SD), d 45.1 (33.1) 25.4 (24.6) <0.001
Ampicillin–sulbactam plus gentamicin, n (%) 170 (58.8) 35 (83.3) <0.001
Ampicillin–sulbactam plus gentamicin, mean (SD), d 10.8 (8.3) 6.8 (7.8) 0.003
Systemic antibacterial therapy, n (%) 177 (61.2) 35 (83.3) 0.002
Systemic antibacterial therapy, mean (SD), d 13.8 (12.3) 8.8 (12.2) 0.01
Note: P value in the first column is from univariate analysis with statistically significant values in bold, P value in the second column is from the
forward step logistic regression.
nCPAP¼ nasal continuous positive airway pressure, NICU¼ neonatal intensive care unit, SD¼ standard deviation.
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acquisition of MDR GNB can be very precocious.33 However,
because screening at admission was not performed, an MDR
GNB acquisition in our NICU cannot be ruled out. Recently,
epidemiological investigations, as well as mathematical mod-
eling, have shown that the transmission dynamics of multidrug-
resistant bacteria crucially depend on the structure of the
underlying healthcare network, as shaped by inter-institutional
referral pattern of patients.34,35 A tertiary NICU, such as that
under study, occupies a central position in the neonatal health-
care network and is, consequently, especially vulnerable to the
spread of previously acquired pathogens.36 Our data suggest to
include in the ASC program an admission screening for MDR
organisms of all outborn patients, or at least of those at higher
risk because referred from other NICUs. The need of a network
based, coordinated regional approach to infection prevention
has also been recently emphasized by authoritative healthcare
agencies.37
Finally, the only independent risk factor for colonization
by multiple MDR GNB species and/or genera was the number
of days of formula feeding. Infant formula is a well-described
pathway for healthcare-acquired infections in NICUs.38,39
Intrinsic and extrinsic contaminations of powdered infant
formula can occur during manufacture, during reconstitution
through the use of contaminated water, utensils, work surfaces,
at the time of feeding, in particular by enteral tubing with
biofilm, or because of inappropriate storage.40 Enterobacter
spp. as well as species/genera that were not speciated (e.g.,
Pantoea spp., Cronobacter spp., E hormaechei, E vulneris, etc.)
have been repeatedly detected in powdered formula.41 This
could have likely contributed, along with the deficiency of a
commensal flora promoted by breast milk, to the high back-
ground prevalence of Enterobacter spp. colonization in
the NICU.
Our study has some limitations. Because weekly surveil-
lance cultures were scheduled at the same day for all infants
staying in NICU regardless of their interval of time since
admission, it was not possible to define when the colonization
by MDR GNBs was acquired. This could be especially relevant
for the outborn infants. However, the need to ensure high
compliance to the ASC program was considered prioritary
and, consequently, according with some authors choosing a
similar option, screening of each neonate at specific and
different time was ruled out.42 Moreover, microbiological
methods of isolation and identification were relatively rough
and lacking of accuracy in speciation of MDR GNBs. Our aim
was, indeed, to obtain epidemiologically meaningful infor-
mation quickly, minimizing at the same time the laboratory
costs and workload.43 The role as risk factors of logistic and
organizational features such as overcrowding, understaffing,
and infection control practices, for example, hand hygiene, was
not assessed. However, the prominent role of the length of stay
in NICU as the only independent variable positively associated
with MDR GNB acquisition as well as the descriptive charac-
teristics of the epidemic clusters, highlight cross-transmission
as the most likely route of colonization. The association
between colonization and infection was only described but
an accurate assessment of the clinical outcome was beyond
the purposes of this study. Scarcity of data from clinical cultures
and limitations related to the low detection rate of the neonatal
blood cultures contributed to this option. Finally, the case mix
of participants in our NICUwas strongly influenced by the level
of the unit and the available services, mainly surgery. Con-
sequently, generalizability of our findings could be limited.
CONCLUSIONS
In conclusion, our study confirms an increasing challenge
of MDR GNB to NICUs. Due to the intrinsic restrictions of the
available treatment options, the upward epidemiological trend
of these organisms is a significant threat to patients admitted to
NICUs, particularly to high-risk infants.
Though there is no agreement about the most cost-effective
strategy of the surveillance cultures in NICU and a universal
once-a-week approach is a compromise solution to warrant a
high and continued adherence, this intervention allowed us to
thoroughly understand the changing epidemiology of MDR
GNB in the NICU setting, to timely detect the import and
spread of new multiresistant clones and institute contact
TABLE 5. Epidemiological and Microbiological Characteristics of the Clusters of Colonization Cases by ESBL-Producing
Escherichia coli and Klebsiella pneumoniae, June 2009 to June 2014, Palermo, Italy
Cluster Year/Quarter No. of Cases
Index Case
Outborn Y/N Organism Phylogroup ST
Genetic Determinant
of Resistance
1 1/I–2/I 5 N E coli A – CTX-M-15
2 2/I – II 4 Y E coli A – DHA-1
321 3/III–4/I 15 Y E coli B2 ST131 CTX-M-15
4 4/I -II 16 N E coli B1 – CTX-M-15
5 4 /III 8 Y E coli B2 ST1092 CTX-M-15
1 1/I 6 Y K pneumoniae – ST10 CTX-M-15
2 1/II–2/I 7 Y K pneumoniae – ST15 CTX-M-15
3 4/I – II 26 Y K pneumoniae – ST29 CTX-M-15
422 4/I – II 10 Y K pneumoniae – ST258 KPC-3
5 4/II 2 Y K pneumoniae – ST530 OXA-48
6 4/II 4 Y K pneumoniae – ST870 SHV-28
7 4/III–IV 25 Y K pneumoniae – ST1564 CTX-M-15
Note: DHA-1 is an AmpC b-lactamase, KPC-3 and OXA-48 are carbapenemases.
21Giuffre` 2013, 22Giuffre` 2013.
ST¼ sequence type.
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precautions, and to assess risk factors for MDR GNB coloniza-
tion. Additionally, collection of these data was an important tool
to optimize antimicrobials use and control the emergence and
dissemination of resistances. The frequent need to treat in the
absence of culture results makes it even more significant the
contribution provided by the active surveillance programs.
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